Targeting the vasculature to enhance anti-tumor immunity
靶向血管系统增强抗肿瘤免疫力
基本信息
- 批准号:10092966
- 负责人:
- 金额:$ 36.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdhesionsAngiogenic FactorAreaAttentionBiological AssayBlood VesselsBrainBrain NeoplasmsBreast Cancer ModelCD8-Positive T-LymphocytesCancer Cell GrowthCell Adhesion MoleculesCell CommunicationCell Culture TechniquesCell LineCell ProliferationCell SurvivalCell divisionCell physiologyCellsCoculture TechniquesComplexCuesCyclin-Dependent Kinase InhibitorCytotoxic T-LymphocytesDNADNA MethylationDNA Modification MethylasesDNA deliveryDevelopmentE-SelectinEndothelial CellsEndotheliumEnvironmentEnzymesEpigenetic ProcessExcisionFGF2 geneFibroblast Growth Factor ReceptorsFlow CytometryGatekeepingGene SilencingGenesGeneticGenetically Engineered MouseGoalsGrowthGrowth FactorHeterogeneityHumanImmuneImmune systemImmunologic SurveillanceImmunosuppressionImmunotherapyImpairmentIn VitroInterferon Type IILabelLinkLymphocyte DepletionMediatingMetastatic malignant neoplasm to brainMethylationMicrofluidic MicrochipsModelingMorphogenesisMusNeoplasm MetastasisNeoplasms in Vascular TissueNormal tissue morphologyPRKCA genePathway interactionsPerfusionPermeabilityPlayPositioning AttributePrimary NeoplasmProtein Kinase CRepressionResearch PersonnelRoleShapesSmall Interfering RNASolid NeoplasmStructureT-LymphocyteTNF geneTropismTumor BiologyTumor BurdenTumor ImmunityTumor-infiltrating immune cellsTyrosine Kinase InhibitorWorkbioluminescence imagingblood vessel developmentcancer cellcancer immunotherapycancer survivalchemokinecombinatorialimmune checkpoint blockadeimmunosuppressedimprovedinhibitor/antagonistinterestloss of functionlymphocyte traffickingmalignant breast neoplasmmethylation patternmonolayermouse modelnanoparticleneoplastic cellneovascularizationrecruitself-renewalsingle-cell RNA sequencingstemstem cellstranscriptome sequencingtreatment strategytumortumor growthtumor microenvironmenttumor progressiontumor-immune system interactions
项目摘要
Tumor-associated endothelial cells (ECs) line the blood vessels that promote the growth and support the
dissemination and survival of cancer cells. The tumor vasculature is also a gatekeeper that controls the
passage of immune cells both into and out of the tumor microenvironment. We recently used single cell RNA
sequencing (sc-RNAseq) to characterize EC heterogeneity in a mammary tumor model; from these studies, we
turned our attention to DNA methyltransferase1 (DNMT1) which has well-defined roles in stem/progenitor cell
self-renewal via it's ability to re-establish patterns of methylation in dividing cells, but no known role in
regulating EC function in tumors. Using mice with conditional deletion of DNMT1 in ECs (DNMT1iECKO mice),
we show inhibition of tumor growth and metastatic seeding and reduced vessel complexity/branching. We
propose these effects are due to a loss of methylation-dependent EC specification required for
neovascularization and are due to de-repression of Th1 chemokines (e.g. Cxcl9/Cxcl10, and Cxcl11) and cell
adhesion molecules (e.g. Vcam1, Icam1/2, and E-selectin) in ECs that recruit and retain cytotoxic T-
lymphocytes to impair tumor growth. In aim 1 we will use DNMT1iECKO mice and vascular-tropic nanoparticles
to determine how targeting DNMT1 regulates EC morphogenesis, perfusion, and permeability during cancer
cell survival. In aim 2 we will use metastasis models to assess how vascular DNMT1 shapes the tumor
immune microenvironment via its ability to regulate cell adhesion molecules (CAMs) and CTL-mobilizing
chemokines in ECs. In aim 3 we will examine mechanisms of immune suppression by a FGF2/DNMT1 axis
that triggers methylation-induced silencing of CAMs and chemokines in tumor-associated ECs. To complete
our goals, we have assembled a team of investigators with expertise in DNA methylation (S. Bhatnager), tumor
immune micro environments (V. Engelhard), and the development of microfluidics devices to study EC-to-T-cell
interactions (R. Kamm). Together, our study characterizes a completely unexplored area; namely, identifying
how methylation-dependent pathways regulate the complex functional diversity, specification, and
immunosuppressive features of tumor-associated ECs.
肿瘤相关内皮细胞(EC)排列在血管中,促进肿瘤生长并支持肿瘤生长。
扩散和癌细胞的存活。肿瘤血管系统也是控制肿瘤细胞增殖的守门人。
免疫细胞进出肿瘤微环境的通道。我们最近使用单细胞RNA
用sc-RNAseq技术来表征乳腺肿瘤模型中EC的异质性;从这些研究中,我们
DNA甲基转移酶1(DNMT 1)在干/祖细胞中具有明确的作用,
通过其在分裂细胞中重新建立甲基化模式的能力进行自我更新,但在
调节肿瘤中EC的功能。使用EC中DNMT 1条件性缺失的小鼠(DNMT 1 iECKO小鼠),
我们显示了对肿瘤生长和转移性接种的抑制以及降低的血管复杂性/分支。我们
我提出这些影响是由于甲基化依赖的EC规格的损失所需的
新血管形成,并且是由于Th 1趋化因子(例如Cxc 19/Cxc 110和Cxc 111)和细胞因子的去抑制所致。
粘附分子(如Vcam 1,Icam 1/2和E-选择素)在EC中募集和保留细胞毒性T细胞,
淋巴细胞,以削弱肿瘤生长。在目标1中,我们将使用DNMT 1 iECKO小鼠和血管嗜性纳米颗粒
确定靶向DNMT 1如何调节癌症期间EC形态发生、灌注和渗透性
细胞存活在目标2中,我们将使用转移模型来评估血管DNMT 1如何塑造肿瘤
免疫微环境通过其调节细胞粘附分子(CAM)和CTL动员的能力
EC中的趋化因子。在目标3中,我们将研究FGF 2/DNMT 1轴的免疫抑制机制
其触发肿瘤相关EC中CAM和趋化因子的甲基化诱导沉默。完成
为了实现我们的目标,我们组建了一个具有DNA甲基化专业知识的研究团队(S。Bhatnager),肿瘤
免疫微环境(V. Engelhard),以及研究EC至T细胞的微流体装置的开发
相互作用(R. Kamm)。总之,我们的研究描述了一个完全未探索的领域;即,识别
甲基化依赖性途径如何调节复杂的功能多样性,规格,
肿瘤相关EC的免疫抑制特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Carl Dudley其他文献
Andrew Carl Dudley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Carl Dudley', 18)}}的其他基金
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
肿瘤内皮细胞对促转移纤维蛋白基质的调节
- 批准号:
10356164 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
肿瘤内皮细胞对促转移纤维蛋白基质的调节
- 批准号:
10179715 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
肿瘤内皮细胞对促转移纤维蛋白基质的调节
- 批准号:
10573196 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Mechanisms of tumor escape from anti-angiogenic therapy
肿瘤逃避抗血管生成治疗的机制
- 批准号:
8693221 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
Mechanisms of tumor escape from anti-angiogenic therapy
肿瘤逃避抗血管生成治疗的机制
- 批准号:
8887312 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
Targeting the vasculature to enhance anti-tumor immunity
靶向血管系统增强抗肿瘤免疫力
- 批准号:
10399410 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
Targeting the vasculature to enhance anti-tumor immunity
靶向血管系统增强抗肿瘤免疫力
- 批准号:
10621205 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
Characterizing tumor endothelial cell abnormalities to develop rational anti-angi
表征肿瘤内皮细胞异常以开发合理的抗血管治疗
- 批准号:
7708266 - 财政年份:2009
- 资助金额:
$ 36.34万 - 项目类别:
Characterizing tumor endothelial cell abnormalities to develop rational anti-angi
表征肿瘤内皮细胞异常以开发合理的抗血管治疗
- 批准号:
8231654 - 财政年份:2009
- 资助金额:
$ 36.34万 - 项目类别:
相似海外基金
How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
- 批准号:
22KJ0818 - 财政年份:2023
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10711027 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10297199 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10625314 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
- 批准号:
10405070 - 财政年份:2021
- 资助金额:
$ 36.34万 - 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
- 批准号:
20K06385 - 财政年份:2020
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
- 批准号:
17K11866 - 财政年份:2017
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
- 批准号:
15K20874 - 财政年份:2015
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
- 批准号:
15K15523 - 财政年份:2015
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
- 批准号:
26860367 - 财政年份:2014
- 资助金额:
$ 36.34万 - 项目类别:
Grant-in-Aid for Young Scientists (B)